Chemo is No Longer Your Only Option

10.14.24,

Chemo is No Longer Your Only Option

For years, chemotherapy has been one of the only options for treating cancer. Now, introducing Privado. They use theranostics for treating prostate cancer which targets only the bad cells, meaning you get to keep your good ones!

For years, chemotherapy has been one of the only options for treating cancer. Now, there is finally another option – theranostics. Privado Health uses theranostics for treating prostate cancer which targets only the bad cells, meaning you get to keep your good ones!

Prostate cancer is the second most common cancer found in men. Chemotherapy has been the leader in cancer treatment, and while it does its job of eradicating the bad cells in patients’ bodies, it also wipes out the good ones. This leads to many uncomfortable side effects like nausea, fatigue, and hair loss.

I believe Privado’s radiopharmaceutical injection is what the future of cancer treatment looks like, so let’s dig into it.

How does Theranostics work?

Theranostics is a tailored and targeted approach that focuses on the unique characteristics of a patient’s cancer. It works efficiently to target malignant cells while avoiding damage to the surrounding healthy tissue. This minimizes side effects and helps the patient stay strong to fight off cancer in just two steps:

Diagnosis: A diagnosis agent is injected into the body, designed specifically to latch onto cancer cells. This makes visualization using imaging techniques easier for doctors. This precise targeting enables a clearer understanding of the cancer’s extent and location.
Treatment: Once the target is acquired, a therapeutic agent is introduced. This is when the radiopharmaceutical is injected, targeting the bad cells with radiation while sparing the good stuff.

Who’s eligible for Theranostics?

Currently, Privado is only treating patients with advanced prostate cancer/ Any inquiries for eligibility can be done through their website HERE!

How is Theranostics Testing?

Theranostics for other types of cancers is still in the clinical trial phase here in the US. But over in Germany, this treatment has helped over 1,000 patients benefit. In some cases, patients saw an 80% eradication after only the first treatment.This revolutionary medicine will soon be the future of cancer treatment. If you’re curious to learn more about how Privado is transforming the landscape of cancer treatment, check out their website HERE!